About Us

Contact us
Community Advisory Board
Readers Rep
Careers
Events
Historical Archives
Recent Quotes
My Watchlist
Indicators
Local Stocks
San Diego Stocks
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Moderna, Inc. - Common Stock (NQ:MRNA)

187.46 -15.75 (-7.75%)
Delayed Quote Updated: 4:00 PM EDT, Oct 6, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Moderna, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
These S&P500 stocks are moving in today's session ↗
Via Chartmill
News headline image
3 Stocks Whose Competitive Walls Tower Over Nvidia's ↗
A solid moat favors revenue growth, and that's good news for investors. 
Via The Motley Fool
Topics Artificial Intelligence
These S&P500 stocks are moving in today's pre-market session ↗
Via Chartmill
News headline image
Is BioNTech Stock a No-Brainer Buy on the Dip? ↗
The company is coming back into the spotlight thanks to recent developments. 
Via The Motley Fool
Stay informed with the top movers within the S&P500 index on Wednesday. ↗
Via Chartmill
News headline image
Moderna Stock Moves Lower Wednesday: What's Going On? ↗
Shares of Moderna Inc (NASDAQ: MRNA) are trading lower Wednesday morning, taking a breather following a 170% surge over the trailing month. 
Via Benzinga
Wednesday's session: gap up and gap down stock in the S&P500 index ↗
Via Chartmill
Wednesday's pre-market session: top gainers and losers in the S&P500 index ↗
Via Chartmill
Exploring the top movers within the S&P500 index during today's session. ↗
Via Chartmill
Which S&P500 stocks are moving on Tuesday? ↗
Via Chartmill
News headline image
Moderna Stock Climbs Tuesday: What's Going On? ↗
Moderna Inc (NASDAQ: MRNA) shares are trading higher Tuesday morning. Here's what investors need to know. 
Via Benzinga
News headline image
Moderna to Present at Upcoming Conferences in September 2026
From Moderna, Inc.
Via ACCESS Newswire
News headline image
Moderna Stock More Than Doubled in August. Is the Stock a Buy, a Hold, or a Sell? ↗
The company may be on track to its next product. 
Via The Motley Fool
Uncover the latest developments among S&P500 stocks in today's session. ↗
Via Chartmill
What's going on in today's pre-market session: S&P500 movers ↗
Via Chartmill
News headline image
Is It Too Late to Buy Moderna Stock After Its 127% Surge? ↗
Moderna could be on the verge of a breakthrough, but the biotech's MRNA cancer vaccine catalyst is overly priced in. 
Via The Motley Fool
News headline image
VOO vs. RSP: If AI Stocks Get Too Concentrated, Here's Which One I'd Choose ↗
These ETFs both hold S&P 500 members but with very different allocations. 
Via The Motley Fool
Topics Artificial Intelligence ETFs Stocks
What's going on in today's session: S&P500 gap up and gap down stocks ↗
Via Chartmill
News headline image
Moderna Announces Pricing of Upsized $2.6 Billion Offering of Convertible Senior Notes
From Moderna, Inc.
Via ACCESS Newswire
News headline image
Q2 Earnings Highlights: Moderna (NASDAQ:MRNA) Vs The Rest Of The Therapeutics Stocks
Wrapping up Q2 earnings, we look at the numbers and key takeaways for the therapeutics stocks, including Moderna (NASDAQ:MRNA) and its peers. Over the next f... 
Via StockStory
Topics Artificial Intelligence
News headline image
Moderna Receives U.S. FDA Approval for Updated 2026-2027 COVID-19 Vaccines
From Moderna, Inc.
Via ACCESS Newswire
What's going on in today's session: S&P500 movers ↗
Via Chartmill
Thursday's session: top gainers and losers in the S&P500 index ↗
Via Chartmill
Which S&P500 stocks are gapping on Thursday? ↗
Via Chartmill
These S&P500 stocks that are showing activity before the opening bell on Thursday. ↗
Via Chartmill
News headline image
Moderna Announces Proposed Private Placement of $2.0 Billion of Convertible Senior Notes
From Moderna, Inc.
Via ACCESS Newswire
What's going on in today's session: S&P500 movers ↗
Via Chartmill
These S&P500 stocks are gapping in today's session ↗
Via Chartmill
News headline image
A Multibillion-Dollar mRNA Cancer Market Is Taking Shape Targeting Lung Cancer’s Biggest Opportunity
EQNX::TICKER_START (NASDAQ:SBFM),(NASDAQ:BNTX),(NYSE:AZN),(NASDAQ:MRNA),(NYSE:BMY) EQNX::TICKER_END 
Via FinancialNewsMedia
News headline image
A Multibillion-Dollar mRNA Cancer Market Is Taking Shape Targeting Lung Cancer’s Biggest Opportunity
A New Generation of Personalized Cancer Treatments Could Open a Multibillion-Dollar Market for Precision Oncology 
From MarketNewsUpdates.com
Via GlobeNewswire
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.